Pedro Gabriel Scardini

1/13 🤔Why does multiple myeloma cause anemia and not pancytopenia? If the issue is infiltration of the bone marrow with plasma cells, wouldn't all cell lines be low? Let's have a look.

👥Retrospective cohort study of Kidney transplant recipients (KTRs) with T2DM with 1:1 Propensity Score Matching (PSM) -> 💊GLP-1 RAs vs no-GLP-1 RAs. 📊Primary outcome: all-cause mortality Secondary outcomes: MACEs and major adverse kidney events (MAKEs). 💥In KTRs with diabetes, GLP-1 RAs were linked to 39% lower mortality and reduced risks of major CV & kidney events. Yet, their use remains low! A major opportunity to improve outcomes! Please read more on #CardiovascularDiabetology👇 cardiab.biomedcentral.com/articles/10.11… @BioMedCentral #KidneyTransplant #GLP1RA #CardioRenal

I am honored by the recognition in this incredible work. Many thanks to the @metaacademy_ofc

Honored to be a co-author in this impactful research! Excited to contribute to advancing knowledge in the field. #CardioTwitter #Cardiology #MedX

Fortunate to contribute to this #MetaAnalysis to @BioMedCentral Grateful for this huge achievement in cardiology 🫀

👥Systematic meta-analysis of 10 RCTs (>22,000 pts - 51.2% w/T2DM) to determine the impact of SGLT2i in pts w/ recent or previous MI. 🗓️Mean age 62 yrs; median FU was 21 months. Main findings: 💥HF hospitalization rates were ⬇️in pts on SGLT2i compared with placebo (RR 0.77; 95% CI 0.69, 0.85; p<0.001). 💥These benefits of SGLT2i were consistent regardless of the timing of the last MI. 💥No statistically significant difference in all-cause mortality was observed between the groups (RR 0.88; 95% CI 0.78, 1.00; p=0.058). Read more on #CardiovascularDiabetology @BioMedCentral 👇 cardiab.biomedcentral.com/articles/10.11…

Cardioneuroablation in Patients with Vasovagal Syncope: An updated systematic review and meta-analysis @Alonzo_Prata @erickatsuyama97 @christiankfuku, @pedroscardini @VanioAntunes @AnaCCoan heartrhythmjournal.com/article/S1547-…

After a long period of hard work, got my Step 2 CK score—beyond thrilled! Now closer to my dream! 🇺🇸 🩺 #MedX #MedTwitter #USMLE #Step2 #Step2CK

Step 1 done✅! Grateful for all the support from my colleagues. On to the next phase. #MedTwitter #step1

Congratulations to our team🫀with the leadership of @pedroscardini

🚨 Exciting news! Our meta-analysis on SGLT2i in MI patients has been accepted for publication in Cardiovascular Diabetology! 🔎 Key findings: ✅ SGLT2i reduced MACE events & heart failure hospitalizations ✅ Supports broader use post-MI Grateful to my co-authors & mentors!🙌

@h2h_research Amazing👏👏👏

Hello #MedTwitter!! We are the Heart-2-Heart Research Group!🌟 We are made of ambitious med students and physicians from 🇧🇷 We aim to produce high-impact research in #Cardiology 🫀 with rigorous methodological standards. Let’s connect #cardiotwitter!!🫀🫀

Very grateful for having found this dedicated group that is always teaching me! (Missing a few participants in the photo) 🤝🏼💕

@christiankfuku @RCardoso_MD @metaacademy_ofc @Alonzo_Prata @marques_julia_ @AnaCCoan congrats on the hard work!! It is just the beginning

As a medical student, presenting my work and connecting with incredible mentors, fellows, and friends at #AHA24 has been truly unforgettable. Moments like this remind me I’m on the right path. Grateful beyond words for everyone who’s supported me, this is just the beginning!

Congrats on this solid work! More to come for sure.

@Mahmoud_Ismayl @MayoProceedings @JAHA_AHA @DrAbdilahi_M @PanithayaC @claireraph @AGoldsweig @MayoClinic @MayoClinicCV @MayoCVFellows Congratulations on your research!! Best of luck.

Excited to have presented our work at #AHA24 with 2 simultaneous publications @MayoProceedings & @JAHA_AHA Agreement of Doppler CFR with PET MFR in ANOCA pts 🔗 sciencedirect.com/science/articl… Racial/ethnic & sex disparities in IHCA. Kudos to @DrAbdilahi_M 🔗 ahajournals.org/doi/10.1161/JA…

@IvoQueiroz2000 Nice meeting you, Ivo. Best of luck in the near future.

Chicago’s view is probably the best I’ve ever seen. Also, the best city I had the pleasure to walk. Over 4 hours of walking that were incredibly secure and beautiful. Thank you #AHA24 for the opportunity to visit this City.

@christiankfuku @AHAScience @erickatsuyama97 👏👏👏👏👏

Last day at #AHA24 @AHAScience🫀 Such an incredible opportunity to connect with fellow colleagues and future mentors. Today, I’ve presented the outstanding research conducted by @erickatsuyama97. AHA Chicago 2024✅ See you next year at New Orleans 🔜 #MedX #MedicalStudent